Abstract
Since the emergence of COVID-19 in Dec. 2019, our knowledge of disease and treatment modalities has evolved significantly. Pregnancy poses a unique challenge in the context of the management of infectious diseases because of the effect of the disease and treatment modalities on the mother and fetus. There has been a lack of active inclusion of pregnant women in various trials including vaccination trials in COVID-19; hence most information on treatment strategies became available from adult non-pregnant population. This article outlines the short review on current management strategies available to the adult pregnant population with COVID-19 in light of available evidence until 30th April 2021.
Highlights
There has been a lack of active inclusion of pregnant women in various trials including vaccination trials in COVID-19; most information on treatment strategies became available from adult non-pregnant population
This article outlines the short review on current management strategies available to the adult pregnant population with COVID-19 in light of available evidence until 30th April 2021
Since the initial identification of SARS CoV-2 (COVID-19) in China in December 2019, it has rapidly spread across the world with its devastating effects [1]
Summary
Since the initial identification of SARS CoV-2 (COVID-19) in China in December 2019, it has rapidly spread across the world with its devastating effects [1]. Efforts to study the disease and develop vaccinations against the virus have accelerated worldwide. There has been a lack of active inclusion of pregnant women in various trials including vaccination trials; most information on treatment strategies became available from adult non-pregnant population [4] [5] [6]. This article outlines the short review on current management strategies available to the adult pregnant population with COVID-19 in light of available evidence until 30th April 2021
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have